Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

[video]Eli Lilly CEO Says Diabetes Is ‘Core Engine’ to Strategy
Bloomberg
Tue, 04/25/17 - 11:20 am
Tags:
Eli Lilly, Dave Ricks, Pharma CEOs, diabetes
Eli Lilly’s 1Q17 Estimates for Elanco
Market Realist
Mon, 04/24/17 - 10:15 am
Tags:
Eli Lilly, Elanco, animal health, earnings
Eli Lilly says breast cancer combination treatment improved survival rates in late-stage trial
Marketwatch
Mon, 04/24/17 - 10:07 am
Tags:
Eli Lilly, advanced breast cancer, clinical trials, abemaciclib
Black box warning? No worries, Valeant bills Siliq as the ‘low-cost’ psoriasis alternative to rivals from Novartis, Eli Lilly
Endpoints
Fri, 04/21/17 - 11:45 am
Tags:
Valeant Pharmaceuticals, Siliq, black box, Eli Lilly, Novartis, psoriasis
Meet the lawyer trying to pry drug pricing secrets out of Big Pharma
Stat
Thu, 04/20/17 - 09:02 pm
Tags:
Big Pharma, drug pricing, Mylan Labs, EpiPen, insulin, Eli Lilly, Novo Nordisk, Sanofi
Growth Expected for Eli Lilly’s 1Q17 Revenue
Market Realist
Thu, 04/20/17 - 08:57 pm
Tags:
Eli Lilly, earnings
Hey Pfizer, Novartis and Eli Lilly. G1 Therapeutics says it can beat all of you in its $115M IPO
Endpoints
Tue, 04/18/17 - 08:58 pm
Tags:
G1 Therapeutics, IPOs, Pfizer, Novartis, Eli Lilly, cancer, R&D
Lilly and Incyte's Loss Is AbbVie and Regeneron's Gain
Motley Fool
Mon, 04/17/17 - 12:07 pm
Tags:
Eli Lilly, Inctye, AbbVie, Regeneron, rheumatoid arthritis, FDA, baricitinib, Humira
The FDA shot down a new rheumatoid arthritis drug — and the companies that make the drug are tumbling
Yahoo/Business Insider
Mon, 04/17/17 - 11:32 am
Tags:
FDA, rheumatoid arthritis, Eli Lilly, Incyte, baricitinib
Biotech Movers: OncoMed, Incyte, Omeros
TheStreet.com
Mon, 04/17/17 - 11:22 am
Tags:
biotech, OncoMed, tarextumab, small cell lung cancer, Incyte, Eli Lilly, baricitinib, Omeros
Eli Lilly and Incyte say FDA failed to approve their rheumatoid arthritis drug
Marketwatch
Fri, 04/14/17 - 10:48 am
Tags:
Eli Lilly, Incyte, FDA, rheumatoid arthritis, baricitinib
We don’t know when (exactly) Lilly will announce the FDA’s baricitinib decision, but watch out for the looming pricing squabble
Endpoints
Thu, 04/13/17 - 11:48 am
Tags:
Eli Lilly, FDA, baricitinib, drug pricing, Incyte
How US Drugmakers Profit From China's Biotech Boom
Investopedia
Thu, 04/13/17 - 11:46 am
Tags:
China, biotech, Merck, Eli Lilly, Tesaro
Merck's Diabetes Franchise And The Perils In Proving A Drug's Medical Value
Forbes
Sat, 04/8/17 - 01:09 pm
Tags:
Merck, diabetes, Januvia, Janumet, Eli Lilly
Barclays Sees Positive Catalysts Ahead for Eli Lilly
TheStreet.com
Sat, 04/8/17 - 01:07 pm
Tags:
Eli Lilly
GSK, Sanofi, Bayer and Lilly join parade of advertisers marching off Fox News host O’Reilly’s TV show
Fierce Pharma
Wed, 04/5/17 - 12:03 pm
Tags:
GSK, Sanofi, Bayer, Eli Lilly, FOX News, drug ads
Rivals multiplying, Pfizer appeals to doctor preferences with Ibrance's latest label win
Fierce Pharma
Tue, 04/4/17 - 10:58 pm
Tags:
Pfizer, Ibrance, Novartis, Kisqali, Eli Lilly, abemaciclib, HER-2 negative breast cancer, breast cancer
Lilly, Pfizer, et al. back Sanofi and Regeneron in PCSK9 patent appeal. AbbVie doesn't
Fierce Pharma
Tue, 04/4/17 - 12:13 am
Tags:
Eli Lilly, Pfizer, Sanofi, AbbVie, Regeneron, patents, PCSK9 inhibitors, Repatha
4 Drug Stocks With Big News Coming in April
Motley Fool
Tue, 04/4/17 - 12:11 am
Tags:
Neurocrine, Incyte, Eli Lilly, Biomarin, Ingrezza, baricitinib, Brineura
Pharma's most-valuable brands? J&J, Pfizer and Merck. Valeant, not so much
Fierce Pharma
Sat, 04/1/17 - 08:14 am
Tags:
JNJ, Pfizer, Merck, AbbVie, Eli Lilly, Bristol-Myers Squibb

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.